R&D / Scientists
Title | Location | Job category | Date posted |
---|---|---|---|
(Senior) Scientist Primary Pharmacology of the Target Incubator Unit (f/m/d)
Aachen, Germany
7 Sep 2024
|
Our approach to pain R&D
We work at the forefront of pain research in our efforts to create effective pain treatments for patients. We use a wide range of modalities and technologies, including biologics, peptides, small molecules, and cell and gene therapies. We cover every step in the development of an innovative medicine and we strive for excellence in everything we do – from target identification through to commercialisation. We constantly aim to strengthen our research capabilities, and we are always open to collaboration with external partners.
Our teams and departments within R&D
The experts in our R&D organisation work across specialised teams that join forces to bring innovations forward. Our Research team uses cutting-edge science to ensure strong human validation of our targets and optimisation of our lead structures. The experts in our Development team create leading development strategies for our compounds that lay the basis for a successful market approval.
Continuously strengthening our in-house capabilities
We use our scientific expertise to design and conduct studies that open up profound new insights into the pathophysiology of pain. Our Translational Science team develops model systems and biomarkers that bridge the gap between pre-clinical and clinical development to increase the success rate of our research projects. Our Development team delivers efficient and robust manufacturing processes, as well as high-quality clinical development strategies that pave the way for innovative medicines to enter the market and serve patients in need.
“Grünenthal is one of the few companies in the pharmaceutical industry that is solely dedicated to innovation in pain research. Our R&D organisation welcomes talented scientists who are enthusiastic about science, patients and our vision of a world free of pain.”
Jan Adams
Chief Scientific Officer
Collaborating with innovative partners
We reinforce our own innovation capabilities by entering into long-term strategic partnerships with leading scientists and institutions around the world. With our Innovation Hub in Boston, we’ve established a centre of excellence for pain research. It invites leading scientists who share our dedicated focus on addressing unmet medical needs in pain to join forces with us to achieve our vision of a world free of pain. Our Innovation Hub features a team of outstanding scientists and medical doctors who initiate and drive innovation projects
or 1.4 billion people worldwide are affected by chronic pain (1)
21
% of chronic pain patients suffer for more than 20 years (2)
78
% of chronic pain patients state that their treatment was not as good as they expected (3)
500
million sick days per year in Europe are caused by musculoskeletal pain alone (4)
60
% of permanent work incapacity in Europe is related to musculoskeletal pain alone (5)
34
billion euros are lost by the European economy due to chronic pain every year (6)